Sami-Sabinsa Group Limited is a renowned player in the health science industry, specializing in nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, probiotics, and enzymes. Founded in 1988 by Dr. Muhammed Majeed, the group has various research divisions. It boasts over 120 research scientists who are dedicated to creating products that meet international standards to address emerging nutritional and health needs globally. In line with its commitment to sustainable development, under the leadership of Dr. Majeed, the group pioneered the contract farming model covering nearly 20,000 acres of land in India. The company holds a significant patent portfolio comprising over 383 granted patents and numerous pending applications worldwide. With seven state-of-the-art manufacturing facilities in Bengaluru, Hyderabad, and Utah (USA), the company adheres to global standards for production. Sami-Sabinsa Group operates internationally, with a presence in 13 countries, including the USA, Australia, Canada, China, Germany, India, Japan, Poland, South Africa, South Korea, Brazil, UAE, and Vietnam. The group stands as a prime example of continuous innovation and commitment to quality in the health science industry.
There is no investment information
No recent news or press coverage available for Sami-Sabinsa Group Limited.